Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Blackstone eyes $5.6bn raise for new GP stakes fund as firms seek liquidity and scale
Blackstone eyes $5.6bn raise for new GP stakes fund as firms seek liquidity and scale Blackstone is looking to raise at least $5.6bn for its latest fund focused on acquiring minority stakes in private equity firms, according to a report by Bloomberg citing sources...
Carlyle and SK Capital boost Bluebird Bio bid, offering flexible payout terms
Carlyle and SK Capital boost Bluebird Bio bid, offering flexible payout terms Private equity firms Carlyle and SK Capital Partners have revised their acquisition agreement with Bluebird Bio, giving shareholders the option to receive $5.00 per share in cash or to...
Apollo-backed Evri teams up with DHL in UK ecommerce logistics merger
Apollo-backed Evri teams up with DHL in UK ecommerce logistics merger DHL has agreed to take a minority stake in UK parcel carrier Evri, in a deal that will see the German logistics giant merge its British ecommerce division with the Apollo-backed operator, as it...